Screening herbal medicines for the recovery of alpha-synuclein-induced Parkinson’s disease model of yeast

[1]  Fangli Tang,et al.  [Protective effect of Pogostemon cablin on membrane fluidity of intestinal epithelia cell in ischemia/ reperfusion rats after ischemia/reperfusion]. , 2009, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

[2]  C. Son,et al.  Trichosanthes kirilowii tuber extract induces G2/M phase arrest via inhibition of tubulin polymerization in HepG2 cells. , 2008, Journal of ethnopharmacology.

[3]  Bu-Yeo Kim,et al.  Pogostemon cablin as ROS Scavenger in Oxidant-induced Cell Death of Human Neuroglioma Cells , 2008, Evidence-based complementary and alternative medicine : eCAM.

[4]  Feiyan Liu,et al.  23,24-Dihydrocucurbitacin B induces G2/M cell-cycle arrest and mitochondria-dependent apoptosis in human breast cancer cells (Bcap37). , 2007, Cancer letters.

[5]  Juanling Fu,et al.  In vitro cytotoxicity assay with selected chemicals using human cells to predict target-organ toxicity of liver and kidney. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[6]  Chun-ching Lin,et al.  Hepatoprotective and antioxidant effects of Cuscuta chinensis against acetaminophen-induced hepatotoxicity in rats. , 2007, Journal of ethnopharmacology.

[7]  J. Parvin,et al.  Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. , 2006, Human molecular genetics.

[8]  A. Linstedt.  Faculty Opinions recommendation of Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. , 2006 .

[9]  S. Lindquist,et al.  α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.

[10]  Songsong Cao,et al.  Torsin-Mediated Protection from Cellular Stress in the Dopaminergic Neurons of Caenorhabditis elegans , 2005, The Journal of Neuroscience.

[11]  T. Sherer,et al.  Ubiquitin–proteasome system and Parkinson's diseases , 2005, Experimental Neurology.

[12]  Michiho Ito,et al.  New sesquiterpene hydroperoxides with trypanocidal activity from Pogostemon cablin. , 2004, Chemical & pharmaceutical bulletin.

[13]  John Q Trojanowski,et al.  Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs , 2004, Nature Medicine.

[14]  Peter T. Lansbury,et al.  Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy , 2004, Science.

[15]  M. Vila,et al.  Genetic clues to the pathogenesis of Parkinson's disease , 2004, Nature Medicine.

[16]  K. Umehara,et al.  Isolation of a New 15-Membered Macrocyclic Glycolipid Lactone, Cuscutic Resinoside A from the Seeds of Cuscuta chinensis: A Stimulator of Breast Cancer Cell Proliferation , 2004, Planta medica.

[17]  P. Højrup,et al.  Proteasomal Inhibition by α-Synuclein Filaments and Oligomers* , 2004, Journal of Biological Chemistry.

[18]  S. Lindquist,et al.  Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology , 2003, Science.

[19]  T. Yoshikawa,et al.  Rosmarinic acid, a major polyphenolic component of Perilla frutescens, reduces lipopolysaccharide (LPS)-induced liver injury in D-galactosamine (D-GalN)-sensitized mice. , 2002, Free radical biology & medicine.

[20]  H. Oh,et al.  Cucurbitacins from Trichosanthes kirilowii as the inhibitory components on tyrosinase activity and melanin synthesis of B16/F10 melanoma cells. , 2002, Planta medica.

[21]  P. Aebischer,et al.  α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  John Q. Trojanowski,et al.  Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease , 2001, Science.

[23]  Michel Goedert,et al.  Alpha-synuclein and neurodegenerative diseases , 2001, Nature Reviews Neuroscience.

[24]  L. Mucke,et al.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.

[25]  R. Bauer,et al.  Two new prenylated 3-benzoxepin derivatives as cyclooxygenase inhibitors from Perilla frutescens var. acuta. , 2000, Journal of natural products.

[26]  K. Kinoshita,et al.  Anti-emetic principles of Pogostemon cablin (Blanco) Benth. , 1999, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[27]  E. Park,et al.  Licochalcone A: An Inducer of Cell Differentiation and Cytotoxic Agent from Pogostemon cabling 1 , 1998, Planta medica.

[28]  K. Sekiya,et al.  Inhibitors of Arachidonate Lipoxygenase from Defatted Perilla Seed , 1998 .

[29]  Shu-wen Huang,et al.  Antioxidant activity of a rosemary extract and its constituents, carnosic acid, carnosol, and rosmarinic acid, in bulk oil and oil-in-water emulsion , 1996 .

[30]  J. Fentem,et al.  In vitro cytotoxicity tests for the prediction of acute toxicity in vivo. , 1994, Toxicology in vitro : an international journal published in association with BIBRA.

[31]  R. Kasai,et al.  Nitrile glucosides and rosmarinic acid, the histamine inhibitor from Ehretia philippinensis , 1994 .

[32]  U. Sankawa,et al.  The screening of Chinese crude drugs for Ca2+ antagonist activity: identification of active principles from the aerial part of Pogostemon cablin and the fruits of Prunus mume. , 1989, Chemical & pharmaceutical bulletin.

[33]  M. Nisa,et al.  Effect of Cuscuta chinensis water extract on 7,12-dimethylbenz[a]anthracene-induced skin papillomas and carcinomas in mice. , 1986, Journal of ethnopharmacology.

[34]  Y. Tsai,et al.  Alpha-bulnesene, a PAF inhibitor isolated from the essential oil of Pogostemon cablin. , 2007, Fitoterapia.

[35]  Leonidas Stefanis,et al.  Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. , 2004, Science.

[36]  P. Højrup,et al.  Proteasomal inhibition by alpha-synuclein filaments and oligomers. , 2004, The Journal of biological chemistry.

[37]  J. Trojanowski,et al.  Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. , 2002, Science.

[38]  J. Ridet,et al.  alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  T. Nakazawa,et al.  Metabolites of orally administered Perilla frutescens extract in rats and humans. , 2000, Biological & pharmaceutical bulletin.

[40]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.

[41]  J. Lamaison,et al.  Hydroxycinnamic derivative levels and antioxidant activity in North American Lamiaceae , 1993 .